- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01225770
Gargling With Green Tea for Prophylaxis of Influenza Infection in Teenagers
Effects of Gargling With Green Tea on Preventing Influenza Infection Among High School Students: A Randomized Clinical Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Influenza infection is the principal cause of acute respiratory illnesses and occurs in epidemic or pandemic worldwide. It spreads easily among high school students and from them to the rest of the community; therefore the prevention of influenza is very important.
Experimental studies have revealed that some components of green tea can prevent influenza infection in vitro. In clinically, gargling with green tea catechins has been reported to have possibilities to preventing influenza infection in adults; however, little clinical evidence in teenagers has so far been existed. Based on this background, the investigators designed a randomized study to evaluate the clinical efficacy of gargling with green tea in preventing influenza infection among high school students.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Hiroshi Yamada, MD, PhD
- Phone Number: +81-54-264-5762
- Email: hyamada@u-shizuoka-ken.ac.jp
Study Contact Backup
- Name: Keiji Matsumoto, Ms
- Phone Number: +81-54-264-5770
- Email: d10902@u-shizuoka-ken.ac.jp
Study Locations
-
-
-
Shizuoka, Japan
- Recruiting
- University of Shizuoka
-
Contact:
- Hiroshi Yamada, MD, PhD
- Phone Number: +81-54-264-5762
- Email: hyamada@u-shizuoka-ken.ac.jp
-
Contact:
- Keiji Matsumoto, Ms
- Phone Number: +81-54-264-5770
- Email: d10902@u-shizuoka-ken.ac.jp
-
Principal Investigator:
- Hiroshi Yamada, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged from 15 to 20 years
- obtained written informed consent from both the student and parent before participation
- possible to gargle during 90 days
- possible to fill in questionnaire
Exclusion Criteria:
- Possessing allergy to green tea
- Possessing history of influenza infection within 6 months before entering the study
- Possessing severe immune disease or whole body infection
- severe cardiac, respiratory, renal, or hepatic dysfunction
- diagnosed as inadequate to participate in the study by student doctor
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Green tea
Gargling with green tea
|
Gargling three times daily for 90 days
|
Active Comparator: water
Gargling with water
|
Gargling three times daily for 90 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the incidence rates of influenza infection
Time Frame: Until 3 months gargling
|
Until 3 months gargling
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
severity of influenza symptoms
Time Frame: until 3 months gargling
|
until 3 months gargling
|
influenza-free time during the study period
Time Frame: until 3 months gargling
|
until 3 months gargling
|
incidence of complications
Time Frame: until 3 months gargling
|
until 3 months gargling
|
incidence rates of upper respiratory tract infections
Time Frame: until 3 months gargling
|
until 3 months gargling
|
incidence of days of absence from school
Time Frame: until 3 months gargling
|
until 3 months gargling
|
occurrence of the adverse events
Time Frame: until 3 months gargling
|
until 3 months gargling
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Hiroshi Yamada, MD, PhD, University of Shizuoka
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CT2010001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Influenza Infection
-
Marshfield Clinic Research FoundationUniversity of Wisconsin, Madison; Centers for Disease Control and PreventionCompletedInfluenza A Virus Infection | Influenza B Virus Infection | Immune Response to Influenza VaccineUnited States
-
The University of Hong KongCompletedAcute Respiratory Infection | Influenza-like Illness | Influenza Virus InfectionHong Kong
-
Evidation HealthUniversity of Washington; Biomedical Advanced Research and Development Authority and other collaboratorsCompletedRespiratory Tract Infections | Influenza A | Influenza Type B | Respiratory Viral Infection | Influenza -Like IllnessUnited States
-
University of ManitobaHoffmann-La RocheWithdrawnInfluenza A Virus Infection | Influenza B Virus InfectionCanada
-
Jiangsu Simcere Pharmaceutical Co., Ltd.CompletedEfficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in ChinaInfluenza A Virus Infection | Influenza B Virus InfectionChina
-
Asociacion Instituto BiodonostiaCompletedInfluenza Virus InfectionSpain
-
Renmin Hospital of Wuhan UniversityUnknownInfluenza Virus InfectionChina
-
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.CytoPharm, Inc.CompletedInfluenza A Virus InfectionTaiwan
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza A Virus InfectionUnited States
-
TaiGen Biotechnology Co., Ltd.R&G Pharma Studies Co.,Ltd.Completed
Clinical Trials on green tea
-
The University of Hong KongCompleted
-
Chiang Mai UniversityCompletedHyperuricemia | GoutThailand
-
Taipei City HospitalNational Yang Ming UniversityCompletedType 2 Diabetes | HyperlipidemiaTaiwan
-
University of ArizonaUnited States Department of DefenseCompletedLung Cancer Prevention
-
University of MinnesotaNational Cancer Institute (NCI)Completed
-
Charite University, Berlin, GermanyCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Texas Tech University Health Sciences CenterNational Center for Complementary and Integrative Health (NCCIH)Completed
-
University of AberdeenLipton Teas and InfusionsRecruitingThe Focus of the Study is Healthy VolunteersUnited Kingdom
-
Hayder Raad AbdulbaqiActive, not recruiting